Abstract:Newcastle disease virus (NDV) is a highly infectious viral disease that impacts birds globally, especially domestic poultry. NDV is a type of avian paramyxovirus which poses a major threat to the poultry industry due to its ability to inflict significant economic damage. The membrane protein, Hemagglutinin-Neuraminidase (HN) of NDV is an attractive therapeutic candidate. It contributes to pathogenicity through various functions, such as promoting fusion and preventing viral self-agglutination, which allows for viral spread. In this study, we used pharmacophore modeling to identify natural molecules that can inhibit the HN protein of NDV. Physicochemical characteristics and phylogenetic analysis were determined to elucidate structural information and phylogeny of target protein across different species as well as members of the virus family. For structural analysis, the missing residues of HN target protein were filled and the structure was evaluated by PROCHECK and VERIFY 3D. Moreover, shape and feature-based pharmacophore model was employed to screen natural compounds' library through numerous scoring schemes. Top 48 hits with 0.8860 pharmacophore fit score were subjected towards structure-based molecular docking. Top 9 compounds were observed witihin the range of -8.9 to -7.5 kcal/mol binding score. Five best-fitting compounds in complex with HN receptor were subjected to predict biological activity and further analysis. Top two hits were selected for MD simulations to validate binding modes and structural stability. Finally, upon scrutinization, A1 (ZINC05223166) emerges as potential HN inhibitor to treat NDV, necessitating further validation via clinical trials.

Inhibitory Effect of the Antimicrobial Peptide Drug R-1 by Marine Brevibacillus Laterosporus Against Newcastle Disease Virus

Effects of Qilanyin and Its Components on NDV Proliferation in CEF

Inhibitory effect of new antimicrobial substance by Bacillus subtilis fmbJ on Newcastle disease virus and infectious Bursal disease virus in vitro]

Inhibition of Newcastle Disease Virus (NDV) Replication by RNA Interference Targeting Phosphoprotein (P) Gene in CEF

Inhibition of Newcastle disease virus replication by RNA interference targeting the matrix protein gene in chicken embryo fibroblasts.

1-Formyl-β-carboline Derivatives Block Newcastle Disease Virus Proliferation through Suppressing Viral Adsorption and Entry Processes

The Antiviral Activity in Vitro of Surfactin

A Raf Kinase Inhibitor Demonstrates Antiviral Activities Both in Vitro and in Vivo Against Different Genotypes of Virulent Newcastle Disease Virus

Screening and identification of nucleocapsid protein-nanobodies that inhibited Newcastle disease virus replication in DF-1 cells

The Effects of Newcastle Disease Virus on Human Leukemia in Vitro

Antiviral Activity of Antimicrobial Lipopeptide from Bacillus Subtilis Fmbj Against Pseudorabies Virus, Porcine Parvovirus, Newcastle Disease Virus and Infectious Bursal Disease Virus in Vitro

A Cell-Penetrating NS5B-Specific Nanobody Inhibits Bovine Viral Diarrhea Virus Replication

Characterisation and Evaluation of Antiviral Recombinant Peptides Based on the Heptad Repeat Regions of NDV and IBV Fusion Glycoproteins

Musashi1 Inhibit the Release of Newcastle Disease Viruses Through Preventing Apoptosis of DF-1 Cells

Computational Exploration and Molecular Dynamic Simulation for the Discovery of Antiviral Agents Targeting Newcastle Disease Virus

Inhibition of Newcastle disease virus replication by lentivirus-mediated RNA interference targeting the P gene in chicken embryo fibroblasts

The effect of stable expression of Raf kinase inhibitor protein(RKIP) on the replication of Newcastle disease virus

In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus

Effect of Antibacterial Peptide of the Rabbits Sacculus Rotundus on Serum Antibody Titers of AIV and Chicken NDV

Assessment of antiviral activity and mechanism of rhein on newcastle disease virus (La Sota strain IV) in vitro

Comparison of the in Vitro Antiviral Activity Between the Chicken Mutant-Type and Wild-Type Mx Proteins